The summary of product characteristics (SPC) for Pfizer's Neurontin (gabapentin) has been updated. Neurontin tablets (600mg and 800mg) are now licensed for the treatment of neuropathic pain. A combined SPC for both Neurontin capsules and tablets replaces all previous versions, says the company.